-- シャレー・ホテルズ（NSE:CHALET、BOM:542399）は、火曜日にインド証券取引所に提出した書類によると、シーズンズ・ホテルズの株式100%を火曜日に取得した。 シャレー・ホテルズの株価は水曜日の取引で2%上昇した。 また、シーズンズ・ホテルズはシャレー・ホテルズの完全子会社となったと付け加えた。
Related Articles
Research
Research Alert: Diageo Q3 Beats On Sequential Recovery; Emerging Markets Offset U.s. Weakness
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Diageo reported Q3 FY 26 (Jun.) net sales of USD4.48B, beating consensus of USD4.27B. Organic net sales growth recovered to 0.3% in Q3 (1H FY 26: -2.8%), above the consensus estimate of a 2.3% decline. We believe the quarter demonstrated geographic diversification benefits, with strong growth in Europe (+8.8%), Latin America (+16.2%), and Africa (+17.1%) offsetting North America (-9.4%) and Asia-Pacific (-0.8%) headwinds. FY 26 guidance remains unchanged, with management anticipating a 2-3% organic net sales decline and flat-to-low-single-digit organic operating profit growth. U.S. spirits faced a 15.4% organic decline, largely due to destocking rather than underlying demand weakness, in our view. We acknowledge Easter timing and FIFA World Cup advance sales provided some benefit, though we also see signs of underlying improvement. CEO Lewis emphasized that actions are underway to address North America competitiveness, with a strategy update planned for August 2026.
$DEO
Research
Research Alert: Diageo Q3 Beats On Sequential Recovery; Emerging Markets Offset U.s. Weakness
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Diageo reported Q3 FY 26 (Jun.) net sales of USD4.48B, beating consensus of USD4.27B. Organic net sales growth recovered to 0.3% in Q3 (1H FY 26: -2.8%), above the consensus estimate of a 2.3% decline. We believe the quarter demonstrated geographic diversification benefits, with strong growth in Europe (+8.8%), Latin America (+16.2%), and Africa (+17.1%) offsetting North America (-9.4%) and Asia-Pacific (-0.8%) headwinds. FY 26 guidance remains unchanged, with management anticipating a 2-3% organic net sales decline and flat-to-low-single-digit organic operating profit growth. U.S. spirits faced a 15.4% organic decline, largely due to destocking rather than underlying demand weakness, in our view. We acknowledge Easter timing and FIFA World Cup advance sales provided some benefit, though we also see signs of underlying improvement. CEO Lewis emphasized that actions are underway to address North America competitiveness, with a strategy update planned for August 2026.
$DEO
Asia
Auro Laboratories Receives EDQM GMP Certification for Tarapur Plant
Auro Laboratories (BOM:530233) received an Attestation of Inspection from the European Directorate for the Quality of Medicines and Healthcare (EDQM) for its Metformin Hydrochloride CEP dossier, according to a Tuesday filing on BSE.Shares of the company rose nearly 4% in Wednesdays trade.The certification confirms compliance with Good Manufacturing Practice (GMP) requirements under EU rules for its MIDC Tarapur facility, the filing said.
$BOM:530233